Literature DB >> 11730610

[Use of alternating antipyretics in the treatment of fever in Spain].

J Díez Domingo1, A Burgos Ramírez, J Garrido García, A Ballester Sanz, E Moreno Carretero.   

Abstract

OBJECTIVE: To assess the frequency of the use of alternating antipyretics among Spanish pediatricians and to analyze the factors that determine this practice.
METHODS: An anonymous survey of practicing pediatricians was conducted. Data on the use of antipyretics were collected. Factors related to alternating antipyretics were assessed by using multivariate correlation analyses.
RESULTS: Three hundred twenty-four questionnaires were reviewed. The mean age of participants was 46.4 18.6 years (29-68 years). Of the responding pediatricians, 22.5 % worked in hospitals, 87.5 % in health centres and 24.7 % in in private practice. A total of 68.8 % of pediatricians (95 % CI: 63.4-73.8 %) alternated antipyretics. The combination of ibuprofen and acetaminophen was recommended by 96.9 %. The use of alternating antipyretics was positively associated with male sex (OR: 0.535; 95 % CI: 0.296-0.967; p 0.038), with few years' experience (OR: 0.952; 95 % CI: 0.922-0.984, p 0.005), with considering ibuprofen the drug of choice (OR: 2.324; 95 % CI: 1.235-4.372; p 0.009) and with the doctor's recommendation that the antipyretic be readministered in the event of slight increases in temperature (OR: 0.529; 95 % CI: 0.310-0.901; p 0.019).
CONCLUSIONS: Despite the lack of scientific evidence to justify the practice, the use of alternating antipyretics is common in the treatment of febrile children. Predictive factors of this practice among pediatricians are male sex, having relatively little experience, considering ibuprofen as the drug of choice and recommending the administration of new doses of antipyretic to control mild fever.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730610

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  7 in total

1.  Association between an excess risk of acute kidney injury and concomitant use of ibuprofen and acetaminophen in children, retrospective analysis of a spontaneous reporting system.

Authors:  Zhihua Yue; Pengli Jiang; He Sun; Jing Wu
Journal:  Eur J Clin Pharmacol       Date:  2014-01-21       Impact factor: 2.953

2.  Alternating Acetaminophen and Ibuprofen versus Monotherapies in Improvements of Distress and Reducing Refractory Fever in Febrile Children: A Randomized Controlled Trial.

Authors:  Shuanghong Luo; Mengdong Ran; Qiuhong Luo; Min Shu; Qin Guo; Yu Zhu; Xiaoping Xie; Chongfan Zhang; Chaomin Wan
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

3.  [Analysis of parental knowledge and care in childhood fever].

Authors:  Maria-Cristina Pérez-Conesa; Inés Sánchez Pina; Saida Ridao Manonellas; Antoni Tormo Esparza; Verónica García Hernando; Marta López Fernández
Journal:  Aten Primaria       Date:  2017-03-11       Impact factor: 1.137

Review 4.  Clinical management of fever in children in Brazil: practical recommendations from an expert panel.

Authors:  Hany Simon Junior; Marcello Creado Pedreira; Silvia Maria de Macedo Barbosa; Tadeu Fernando Fernandes; Ana Maria de Ulhôa Escobar
Journal:  Einstein (Sao Paulo)       Date:  2022-08-08

5.  Knowledge, attitudes and misconceptions of primary care physicians regarding fever in children: a cross sectional study.

Authors:  Figen Demir; Ozgur Sekreter
Journal:  Ital J Pediatr       Date:  2012-09-05       Impact factor: 2.638

6.  Alternating ibuprofen and acetaminophen in the treatment of febrile children: a pilot study [ISRCTN30487061].

Authors:  Mona M Nabulsi; Hala Tamim; Ziyad Mahfoud; Mohammad Itani; Ramzi Sabra; Fadi Chamseddine; Mohammad Mikati
Journal:  BMC Med       Date:  2006-03-04       Impact factor: 8.775

7.  Randomized comparative trial of efficacy of paracetamol, ibuprofen and paracetamol-ibuprofen combination for treatment of febrile children.

Authors:  Falgun Indravadan Vyas; Devang Ashwinkumar Rana; Piyush M Patel; Varsha Jitendra Patel; Rekha H Bhavsar
Journal:  Perspect Clin Res       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.